Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$40.29 - $82.51 $12,087 - $24,753
300 New
300 $12,000
Q4 2022

Jan 31, 2023

BUY
$63.98 - $85.37 $44,786 - $59,759
700 New
700 $51,000
Q4 2021

Jan 27, 2022

BUY
$75.08 - $121.99 $292,812 - $475,761
3,900 New
3,900 $245,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.88B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Nova R Wealth, Inc. Portfolio

Follow Nova R Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nova R Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nova R Wealth, Inc. with notifications on news.